Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
US5196435A · kind A · utility
27Cited by
8References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 1991 |
| Grant date | Mar 23, 1993 |
| Priority date | — |
| Expiry date | Nov 21, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Derivatives of melatonin and the pharmaceutically acceptable salts thereof are useful for therapeutically treating hormonally dependent mammalian breast carcinoma. Combination treatments of melatonin derivatives and an antiestrogen compound are especially useful.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.